Understanding Castleman Disease and its Treatment Needs
ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease
This study is looking at Castleman disease, a rare condition that causes swollen lymph nodes and inflammation, to learn more about its different types and how they respond to treatments, so we can create better guidelines for helping patients feel better over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10893420 on NIH RePORTER |
What this research studies
This research focuses on Castleman disease (CD), a rare group of hematologic disorders that cause enlarged lymph nodes and systemic inflammation. The project aims to gather comprehensive data on the different subtypes of CD, including unicentric and multicentric forms, to better understand their underlying mechanisms and treatment responses. By centralizing clinical data and identifying biomarkers, the research seeks to establish evidence-based guidelines for diagnosis and treatment, ultimately improving patient outcomes. Patients will be monitored over time to assess the effectiveness of various treatment approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with any form of Castleman disease, particularly those experiencing severe symptoms or treatment challenges.
Not a fit: Patients with other unrelated hematologic disorders or those not diagnosed with Castleman disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with Castleman disease.
How similar studies have performed: While research on Castleman disease is limited, similar approaches in studying rare diseases have shown promise in improving understanding and treatment outcomes.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Fajgenbaum, David C — University of Pennsylvania
- Study coordinator: Fajgenbaum, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.